Mainz BioMed N.V. | WebDisclosure

Basculer en Français

9807	Companies
196719	Keywords
127725	Articles
104586	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 01/21/2025 at 14:01, 1 year ago

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
Mainz Biomed initiates U.S. clinical study to evaluate next-generation CRC test on advanced adenomas over large patient population. Study targets topline results by Q4 2025, focusing on biomarkers and AI algorithm

Clinical Study Mainz Biomed CRC Screening Next Generation Test Advanced Adenomas
BRIEF

published on 12/19/2024 at 14:05, 1 year 1 month ago

Mainz Biomed s'associe à Quest Diagnostics pour un essai de dépistage du cancer

Essais Cliniques Cancer Colorectal Approbation De La FDA Partenariat En Matière De Santé Services De Diagnostic
BRIEF

published on 12/19/2024 at 14:05, 1 year 1 month ago

Mainz Biomed Partners with Quest Diagnostics for Cancer Screening Trial

FDA Approval Clinical Trials Colorectal Cancer Diagnostic Services Healthcare Partnership
PRESS RELEASE

published on 12/19/2024 at 14:00, 1 year 1 month ago

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Mainz Biomed forms agreement with Quest Diagnostics to provide clinical trials lab services for colorectal cancer screening test, enhancing early cancer detection efforts

Clinical Trials Early Detection Mainz Biomed Colorectal Cancer Screening Quest Diagnostics
BRIEF

published on 11/29/2024 at 14:50, 1 year 2 months ago

Mainz Biomed annonce un regroupement d'actions inversé pour améliorer sa conformité avec le Nasdaq

Approbation Des Actionnaires Mayence Biomed Regroupement D'actions Prix Du Marché Conformité Au Nasdaq
BRIEF

published on 11/29/2024 at 14:50, 1 year 2 months ago

Mainz Biomed Announces Reverse Stock Split to Enhance Nasdaq Compliance

Reverse Stock Split Shareholder Approval Nasdaq Compliance Market Price Mainz Biomed
PRESS RELEASE

published on 11/29/2024 at 14:45, 1 year 2 months ago

Mainz Biomed Announces Stock Split
Mainz Biomed N.V. announces a 1-for-40 reverse stock split to comply with Nasdaq listing standards and increase investor appeal. Effective from December 3, 2024

Investors Nasdaq Mainz Biomed Molecular Genetics Stock Split
BRIEF

published on 11/12/2024 at 15:05, 1 year 2 months ago

Mainz Biomed collabore avec Thermo Fisher pour le développement d'un dépistage du cancer

Mayence Biomed Dépistage Du Cancer Détection Colorectale Partenariat Avec Thermo Fisher Collaboration En Biotechnologie
BRIEF

published on 11/12/2024 at 15:05, 1 year 2 months ago

Mainz Biomed Collaborates with Thermo Fisher for Cancer Screening Development

Cancer Screening Mainz Biomed Colorectal Detection Thermo Fisher Partnership Biotech Collaboration
PRESS RELEASE

published on 11/12/2024 at 15:00, 1 year 2 months ago

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
Mainz Biomed and Thermo Fisher Scientific sign a collaboration agreement for the development of next generation colorectal cancer screening product for global markets

Global Markets Thermo Fisher Scientific Mainz Biomed Collaboration Agreement Colorectal Cancer Screening

Accesswire

Published on 02/05/2026 at 09:05, 1 hour 44 minutes ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 9 hours 14 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 10 hours 49 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 12 hours 24 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 16 hours 49 minutes ago

Lithium South AGSM Update

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 10:05, 44 minutes ago

VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 44 minutes ago

Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago

Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago

Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 1 hour 49 minutes ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY

Les Echos

Published on 02/04/2026 at 18:04, 16 hours 45 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 16 hours 45 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 17 hours 4 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 17 hours 4 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 17 hours 4 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE